Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Cash & Equivalents (2017 - 2025)

Cirtran filings provide 14 years of Cash & Equivalents readings, the most recent being $9589.0 for Q4 2025.

  • On a quarterly basis, Cash & Equivalents changed N/A to $9589.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $9589.0, a N/A change, with the full-year FY2025 number at $9589.0, changed N/A from a year prior.
  • Cash & Equivalents hit $9589.0 in Q4 2025 for Cirtran, down from $19274.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $198891.0 in Q1 2023 to a low of $1210.0 in Q1 2025.
  • Median Cash & Equivalents over the past 5 years was $18081.0 (2022), compared with a mean of $30479.7.
  • Biggest five-year swings in Cash & Equivalents: surged 420.96% in 2023 and later crashed 98.49% in 2024.
  • Cirtran's Cash & Equivalents stood at $5472.0 in 2021, then skyrocketed by 230.43% to $18081.0 in 2022, then grew by 29.43% to $23402.0 in 2023, then tumbled by 87.2% to $2996.0 in 2024, then surged by 220.06% to $9589.0 in 2025.
  • The last three reported values for Cash & Equivalents were $9589.0 (Q4 2025), $19274.0 (Q3 2025), and $4335.0 (Q2 2025) per Business Quant data.